| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.0M | +673.7% | -44.6% |
| Cost of Revenue | $661K | +747.4% | -49.5% |
| Gross Profit | $368K | +569.1% | -33.2% |
| R&D Expense | $310K | +25.5% | -5.8% |
| SG&A Expense | $1.8M | +9.8% | +9.2% |
| Operating Income | -$1.8M | +4.8% | -22.1% |
| Net Income | -$1.4M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $10.5M | -15.0% | -27.6% |
| Accounts Receivable | $324K | +1196.0% | -56.7% |
| Current Assets | $11.7M | -10.9% | -26.6% |
| Total Assets | $12.7M | -10.4% | -25.4% |
| Current Liabilities | $3.6M | -3.3% | +67.0% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.5M | — | — |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | -$78K | — | — |
| Financing Cash Flow | -$17K | — | — |
| Free Cash Flow | -$3.5M | — | — |
| +14.9% |
| -23.7% |
| EPS (Basic) | -$0.03 | +0.0% | -50.0% |
| $3.7M |
| -3.9% |
| +61.6% |
| Stockholders' Equity | $9.1M | -12.8% | -38.8% |